[1]
“Biochemical relationship between leiomyosarcoma and peroxiredoxin-6 expression level: Clinical implications”, IJBB, vol. 59, no. 5, pp. 552–557, Jun. 2023, doi: 10.56042/ijbb.v59i5.60827.